Stable Isotope In-Vivo Labeling for Mass-Spectrometry Identification of Paternal Metabolites Transferred from Sperm to Oocyte During Fertilization
June 17th, 2025
This procedure aims to identify metabolites transferred from sperm to oocytes during fertilization by using stable isotope labeling with 2H2O or U13C Glucose followed by metabolomic analysis. Deuterium-labeled sires are mated with unlabeled dams. Collected pre-implantation embryos are analyzed by mass spectrometry to sort paternal (deuterated) from maternal (non-deuterated) metabolites.
Our research aims to identify paternal metabolites transfer to the zygote at fertilization, uncovering paternal role in early development and epigenetic inheritance beyond just DNA allelic sequences. Paternal contribution to embryo genetics has been so far ascribed only to allelic DNA sequences. Now, we know that epigenetic factors, DNA methylation, histone modifications, and regulatory RNAs play crucial roles in paternal inheritance and influence embryonic development. Currently the field of intergenerational inheritance is making use of epigenetic analytical platform like NGS to identify methylation status of paternal chromosome and of microRNAs and RNA signatory fragments. Challenges consist mostly in trying to develop instrumentation able to collect information at single-germ cell and single-zygote resolution, especially for metabolomic and lipidomic analysis. Future work will explore functional roles of identified the metabolites, assessing their physiological roles by inhibiting their signaling at fertilization. By using specific inhibitors of the intracellular pathways, these stimulate in embryos.
[Instructor] To extract lipid and polar metabolites, obtain mice oocytes and sperm samples. Equilibratethem on ice at four degrees Celsius. Add 225 microliters of ice cold methanol to each sample. Then place the samples in a freezer set to minus 30 degrees Celsius for one minute. Transfer the samples to a sonic bath and incubate for 10 minutes. Next, pipette 750 microliters of ice cold MTBE into the samples. Incubate the samples in a thermo mixer for one hour at four degrees Celsius at 550 RPM. Centrifuge the samples at 13,000 RPM for 10 minutes. Then add 188 microliters of water to each tube. Separate the upper phase containing lipids from the lower phase containing polar metabolites. Dry both phases completely in a vacuum concentrator. Store the dried samples at -80 degrees Celsius. To extract steriles, place the oocyte and sperm samples on ice at four degrees Celsius. Resuspend each sample in 500 microliters of 70% methanol and water solution. Then transfer the suspension to a labeled glass tube. Vortex the samples for 30 seconds to homogenize. Allow the homogenate to rest at four degrees Celsius for 16 hours. Now, centrifuge the homogenized samples at 3,220 G for 15 minutes at room temperature. Transfer the supernatant to new glass tubes. Pipette 500 microliters of PBS into the tubes. Now, add seven milliliters of ice cold diethyl ether to each tube. Vortex the suspension for one minute. Submerge the glass tube in a dry ice and acetone bath to freeze the water phase. After letting the sample sit for two minutes to allow phase separation, transfer the unfrozen diethyl ether phase into a new tube. Repeat the extraction process by adding diethyl ether and isolating the upper phase as before. Combine all collected diethyl ether layers in one glass tube. Dry the final combined extract using a vacuum concentrator. Store the dried sterile samples at -80 degrees Celsius. Bring the dried samples to room temperature to equilibrate. Add 50 microliters of pyridine to solubilize the samples. Add 25 microliters of BSTFA to the tubes for derivatization. Incubate the samples for 90 minutes at 60 degrees Celsius before further analysis. Deuterium-labeled cholesterol derived from sperm was detected in labeled morulae, confirming paternal cholesterol transfer during fertilization. Principle component analysis revealed distinct clustering of labeled morulae from unlabeled morulae, unlabeled oocytes, and labeled sperm cells, indicating unique metabolic profiles post fertilization. Heat map analysis of 50 key metabolites showed that labeled morulae had a distinct metabolic signature compared to other sample groups.
View the full transcript and gain access to thousands of scientific videos
Overview
This study investigates the transfer of paternal metabolites to the zygote at fertilization, emphasizing their role in early development and epigenetic inheritance. By employing stable isotope labeling, the research identifies specific metabolites from sperm that contribute to the metabolic profile of pre-implantation embryos.
Key Study Components
Research Area
- Epigenetic inheritance
- Paternal contributions to embryo development
- Metabolomic analysis
Background
- Paternal influence traditionally linked only to DNA sequences.
- Emerging evidence highlights the importance of epigenetic factors.
- Challenges in measuring metabolites at single-germ cell resolution.
Methods Used
- Stable isotope labeling with 2 H 2 O or U 13 C Glucose
- Mice oocytes and sperm samples as biological systems
- Mass spectrometry for metabolomic analysis
Main Results
- Detection of deuterium-labeled cholesterol confirming its transfer during fertilization.
- Distinct metabolic profiles of labeled morulae identified through principal component analysis.
- Heat map analysis revealed unique signatures of key metabolites.
Conclusions
- The study demonstrates that paternal metabolites play a significant role in embryonic development.
- Findings enhance understanding of intergenerational inheritance mechanisms.
Frequently Asked Questions
Executive Industry Relevance
Stable isotope in-vivo labeling combined with mass spectrometry enables direct tracing of paternal metabolite transfer during fertilization, addressing a critical gap in understanding epigenetic inheritance mechanisms. This approach elevates predictive confidence in early developmental biology by revealing non-genetic paternal contributions that may influence offspring health. The method supports risk-adjusted decision-making for discovery-stage programs investigating metabolic and epigenetic determinants of disease susceptibility.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of paternal metabolic contributions to embryonic development beyond DNA sequence.
- Supports mechanistic de-risking by clarifying the role of sperm-derived metabolites in epigenetic inheritance.
- Facilitates functional target validation for metabolic and epigenetic pathways implicated in disease predisposition.
Screening & Assay Development
- Establishes validated workflows for stable isotope labeling and metabolite extraction in reproductive model systems.
- Delivers reproducible, quantitative mass spectrometry outputs for downstream comparative analyses.
- Prepares biological samples for high-confidence screening of metabolic and epigenetic modulators.
Translational & Preclinical Research
- Aligns metabolic profiling with disease-relevant models to assess intergenerational risk factors.
- Enables continuity from discovery of paternal metabolic signals to preclinical evaluation of their physiological impact.
- Supports translational biomarker identification for metabolic and epigenetic inheritance studies.
Pipeline & Workflow Integration
This method integrates into the discovery-to-preclinical continuum by enabling direct measurement of paternal metabolite transfer and its downstream effects on embryonic metabolic profiles.
- Discovery Biology: Provides robust hypothesis testing for non-genetic inheritance mechanisms via stable isotope tracing.
- Screening: Delivers standardized, quantitative metabolomic readouts suitable for comparative and functional studies.
- Analytics: Employs principal component and heat map analyses to distinguish metabolic signatures across sample groups.
- Translational Research: Bridges early discovery findings to preclinical models assessing disease susceptibility linked to paternal metabolic input.
- Enterprise Reuse: Offers a reusable platform for investigating environmental, dietary, or toxicological impacts on paternal metabolic inheritance.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in target validation and mechanistic understanding of epigenetic inheritance.
- Operational Value: Standardizes metabolite extraction and labeling protocols for reproducibility and scalability.
- Strategic Value: Informs go/no-go decisions by clarifying biological risk in early-stage programs.
- Portfolio Impact: Enables risk-adjusted prioritization of discovery assets targeting metabolic and epigenetic pathways.
Implementation Considerations
- Requires expertise in stable isotope labeling, mass spectrometry, and metabolomics data analysis.
- Demands access to high-sensitivity analytical instrumentation and validated extraction protocols.
- Necessitates cross-team standardization for sample preparation and data interpretation.
- Adaptable to various mammalian model systems with protocol optimization.
- Single-cell and single-zygote resolution remain technical challenges for broader implementation.
